Thrombolex, Inc. — Form D

Thrombolex, Inc. of Kingston, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-12. The offering totals $51.1M, of which $32.8M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
David A. BonitaDirectorKingston, NJ
Michael J. CerminaroDirectorKingston, NJ
Clay A. DeMarcusDirectorKingston, NJ
Keegan A. HarperDirectorKingston, NJ
Sam A. LiangDirectorKingston, NJ
Paul A. StewartDirectorKingston, NJ
Marvin J. WoodallDirectorKingston, NJ
John J. CerminaroExecutive OfficerKingston, NJ
Michael J. CerminaroExecutive OfficerKingston, NJ
Marvin J. WoodallExecutive OfficerKingston, NJ
John A CerminaroExecutive OfficerKingston, NJ
Marvin J WoodallDirectorKingston, NJ
Marvin J WoodallExecutive OfficerKingston, NJ
Kelly A ElliottDirectorKingston, NJ
Todd A RichmondDirectorKingston, NJ
Michael J CerminaroDirectorKingston, NJ
Michael J CerminaroExecutive OfficerKingston, NJ
Michael J CerminaroPromoterKingston, NJ
Tony J LitwillerExecutive OfficerKingston, NJ
Marvin WoodallDirectorRaleigh, NC
Marvin WoodallExecutive OfficerRaleigh, NC
Marvin WoodallPromoterRaleigh, NC
Paul A StewartDirectorMilwaukee, WI
Brian G FirthDirectorKingston, NJ
Brian G FirthExecutive OfficerKingston, NJ

Other filings by this issuer (7)

FiledFormOfferingSold
2024-06-21D$5.0M$1.2M
2024-05-28D$4.8M$4.8M
2022-08-30D$2.0M$2.0M
2021-11-29D$5.0M$5.0M
2020-02-03D/A$9.8M
2018-04-17D/A$3.5M
2017-04-17D$1.5M$400K

More